A Phase Ib Trial to Evaluate the Safety and Efficacy of FMT and Nivolumab in Subjects With Metastatic or Inoperable Melanoma, MSI-H, dMMR or NSCLC

NCT04521075 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma Stage IV
Unresectable Melanoma
NSCLC Stage IV

Interventions

BIOLOGICAL: Fecal Microbial Transplantation by capsules

Sponsor

Ella Therapeutics Ltd